This inventor holds 38 USPTO granted patents and 10 published patent applications, plus 5 CIPO patents and 11 EPO patents. Top assignees: Cascade Biosystems, Inc., Rtx Corporation, Goodrich Corporation. Active years: 1988-2026.
Location History:
- Sarasota, FL (US) (1988)
- Culver City, CA (US) (2001)
- East Longmeadow, CT (US) (2016)
- Colfax, WI (US) (2012 - 2022)
- East Longmeadow, MA (US) (2016 - 2024)
Company Filing History:
23 out of 23 
4 out of 1,560 
3 out of 1,948 
Years Active: 1988-2026
Title: Kenneth D. Smith: Innovator in RNA Detection Technologies
Introduction
Kenneth D. Smith, based in Colfax, WI, is a notable inventor with an impressive portfolio of 23 patents. His work primarily focuses on advancements in molecular biology, particularly in methods for assessing RNA expression and detecting target nucleic acids. As a key contributor in his field, Smith's innovations pave the way for improved diagnostic tools and research methodologies.
Latest Patents
Among his latest contributions, Kenneth D. Smith has developed two significant patents:
1. **Methods and Materials for Assessing RNA Expression**: This patent outlines innovative methods and materials designed for detecting the presence, absence, or quantity of target nucleic acid, specifically target RNA or target cDNA produced from target RNA. The document emphasizes the creation of kits for these detection purposes, along with detailed methods for manufacturing such kits.
2. **Detecting Nucleic Acid**: This patent focuses on the detection of target nucleic acids, providing comprehensive methods and materials for identifying their presence or absence, as well as quantifying them in a sample. It also includes discussions around kits that facilitate these detection methods and instructions on kit production.
Career Highlights
Kenneth D. Smith is currently associated with Cascade Biosystems, Inc., where he plays a pivotal role in advancing biotechnological solutions. His work has garnered attention in the field of molecular genetics and diagnostics, enhancing the capabilities of researchers and clinicians alike.
Collaborations
Throughout his career, Smith has collaborated with talented professionals, including Nina Yazvenko and Mariya Smit. These partnerships have likely contributed to the enrichment of his research and the successful development of his innovative patents.
Conclusion
Kenneth D. Smith exemplifies the spirit of innovation in the life sciences sector with his robust array of patents and pivotal work at Cascade Biosystems, Inc. His contributions to RNA detection and assessment continue to influence advancements in molecular biology, solidifying his position as a prominent figure in the field.